These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8306317

  • 1. Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression.
    Kim TM, Benedict WF, Xu HJ, Hu SX, Gosewehr J, Velicescu M, Yin E, Zheng J, D'Ablaing G, Dubeau L.
    Cancer Res; 1994 Feb 01; 54(3):605-9. PubMed ID: 8306317
    [Abstract] [Full Text] [Related]

  • 2. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
    Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL, Li J, Podratz KC, Jenkins RB, Benedict WF.
    Cancer Res; 1994 Feb 01; 54(3):610-3. PubMed ID: 8306318
    [Abstract] [Full Text] [Related]

  • 3. Retinoblastoma protein expression in ovarian epithelial neoplasms.
    Niemann TH, Trgovac TL, McGaughy VR, Lewandowski GS, Copeland LJ.
    Gynecol Oncol; 1998 Jun 01; 69(3):214-9. PubMed ID: 9648590
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
    Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R.
    Cancer Res; 1991 Oct 15; 51(20):5736-43. PubMed ID: 1913692
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A.
    Gynecol Oncol; 2004 Dec 15; 95(3):449-55. PubMed ID: 15581945
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA.
    Mol Carcinog; 1996 Feb 15; 15(2):85-95. PubMed ID: 8599583
    [Abstract] [Full Text] [Related]

  • 20. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV, Rodabaugh KJ, Welch WR, Berkowitz RS, Mok SC.
    Oncogene; 1998 Jan 29; 16(4):555-9. PubMed ID: 9484846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.